These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23766784)

  • 1. Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS).
    Limpert AS; Mattmann ME; Cosford ND
    Beilstein J Org Chem; 2013; 9():717-32. PubMed ID: 23766784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
    Kalmar B; Lu CH; Greensmith L
    Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the pathogenesis of amyotrophic lateral sclerosis.
    Shaw CE; al-Chalabi A; Leigh N
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):69-76. PubMed ID: 11898502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art and the dark side of amyotrophic lateral sclerosis.
    Musarò A
    World J Biol Chem; 2010 May; 1(5):62-8. PubMed ID: 21540991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis.
    Chakraborty A; Diwan A
    AIMS Neurosci; 2022; 9(4):423-443. PubMed ID: 36660079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.
    Parakh S; Jagaraj CJ; Vidal M; Ragagnin AMG; Perri ER; Konopka A; Toth RP; Galper J; Blair IP; Thomas CJ; Walker AK; Yang S; Spencer DM; Atkin JD
    Hum Mol Genet; 2018 Apr; 27(8):1311-1331. PubMed ID: 29409023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
    Wei Y; Zhong S; Yang H; Wang X; Lv B; Bian Y; Pei Y; Xu C; Zhao Q; Wu Y; Luo D; Wang F; Sun H; Chen Y
    Eur J Med Chem; 2024 Jun; 272():116496. PubMed ID: 38759454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
    Elmansy MF; Reidl CT; Rahaman M; Özdinler PH; Silverman RB
    Med Res Rev; 2023 Nov; 43(6):2260-2302. PubMed ID: 37243319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
    McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
    Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N
    Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
    Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
    Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting.
    Browne EC; Abbott BM
    Eur J Med Chem; 2016 Oct; 121():918-925. PubMed ID: 27012524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
    Oh YK; Shin KS; Yuan J; Kang SJ
    J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Strategies and Metal-Induced Oxidative Stress: Application of Synchrotron Radiation Microbeam to Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan.
    Yoshida S
    Front Neurol; 2022; 13():884439. PubMed ID: 35837234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Tokuda E; Furukawa Y
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
    Furukawa Y; Tokuda E
    Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cysteine (Cys) Residues Cys-6 and Cys-111 in Mutant Superoxide Dismutase 1 (SOD1) A4V Are Required for Induction of Endoplasmic Reticulum Stress in Amyotrophic Lateral Sclerosis.
    Perri ER; Parakh S; Vidal M; Mehta P; Ma Y; Walker AK; Atkin JD
    J Mol Neurosci; 2020 Sep; 70(9):1357-1368. PubMed ID: 32445072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
    Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.